Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Dendreon Corporation    

End-of-day quote. End-of-day quote  - 06/11
0.0325 USD   -4.41%
2015DJValeant Approved to Buy Dendreon Assets for $495 Million
2015 Drugmaker Valeant close to buying Salix - source
2015 VALEANT SECURES : Bloomberg
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2014 299 M
EBIT 2014 -57,0 M
Net income 2014 -107 M
Debt 2014 -
Yield 2014 -
Sales 2015 327 M
EBIT 2015 -56,8 M
Net income 2015 -73,1 M
Debt 2015 421 M
Yield 2015 -
P/E ratio 2014 -
P/E ratio 2015
EV / Sales 2014 0,02x
EV / Sales 2015 1,30x
Capitalization 5,40 M
More Financials
Company
Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients.The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular... 
More about the company
Surperformance© ratings of Dendreon Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on DENDREON CORPORATION
2015 DENDREON : Regulation FD Disclosure, Change in Directors or Principal Officers (..
2015 DENDREON : Material Modification to Rights of Security Holders, Regulation FD Di..
2015 DENDREON : Regulation FD Disclosure (form 8-K)
2015 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
2015 DENDREON : Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results
2015 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2015 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2015 DENDREON : Other Events (form 8-K)
More news
Sector news : Biotechnology & Medical Research - NEC
02:33p LONZA : Education Great Bay, UNH Manchester offer biotech program Department of ..
02:08p FDA panel recommends approval for copy of arthritis drug Remicade
10:32a INCYTE : Nasdaq 100 Movers: INCY, TRIP
More sector news : Biotechnology & Medical Research - NEC
Comments 
Advertisement
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | US24823Q1076 | 4-Traders
Full-screen chart
Technical analysis trends DENDREON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions